company? Let’s change
that.
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.
First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted
Phrixus Pharmaceuticals develops and commercializes heart failure-related pharmaceutical products and therapies.
Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation.
Helping Make Research Possible We are helping make research possible by supplying scientists worldwide with the assay kits, antibodies, proteins, and biochemicals to advance their research. We know the scientific community needs more than our products, so our 100 in-house scientists, the same who design and develop our products, connect with researchers to answer questions, provide resources, and offer contract research services. We offer tools for diverse research areas, including cancer, inflammation, nitric oxide, neuroscience, epigenetics, diabetes, apoptosis, oxidative injury, endocrinology, atherosclerosis, and many more. We are also a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.
Akadeum Life Sciences, an emerging life science startup, is located in Ann Arbor, MI. Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached. At Akadeum, we strive to disrupt the status quo by delivering a technology that can isolate any sample, any volume, anywhere.
MI Bioresearch is a contract research organization providing in vivo preclinical imaging services.
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds
OncoFusion Therapeutics is engaged in the R&D of personalized therapeutics for patients with genetically defined cancers.
Forever Labs banks your stem cells to help you live healthier, longer.
Swift Biosciences develops molecular biology reagents for research and diagnostic applications.
Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.
Work Your Passion. Live Your Purpose.